tiprankstipranks
Trending News
More News >
Amplifon S.p.A. (IT:AMP)
:AMP

Amplifon S.p.A. (AMP) AI Stock Analysis

Compare
40 Followers

Top Page

IT:AMP

Amplifon S.p.A.

(AMP)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 4o)
Rating:57Neutral
Price Target:
€14.00
▲(3.02% Upside)
The overall stock score reflects a stable financial position with strong cash flow generation, but is offset by declining revenue and profitability margins. Technical indicators suggest a bearish trend, and the stock appears overvalued based on its P/E ratio.
Positive Factors
Cash Flow Generation
Strong free cash flow growth indicates improved cash generation capabilities, providing financial flexibility for reinvestment and debt reduction.
Business Model Strength
The direct-to-consumer model enhances customer engagement and control over distribution, supporting stable revenue streams and market presence.
Partnerships and Alliances
Partnerships with manufacturers allow access to diverse products and competitive pricing, strengthening market position and customer offerings.
Negative Factors
Declining Revenue
Negative revenue growth suggests challenges in sales expansion, potentially impacting long-term profitability and market share.
Profitability Margins
Decreased net profit margins indicate reduced profitability, which may affect the company's ability to invest in growth and innovation.
High Leverage
High leverage can pose financial risks, limiting the company's ability to manage economic downturns and invest in strategic opportunities.

Amplifon S.p.A. (AMP) vs. iShares MSCI Italy ETF (EWI)

Amplifon S.p.A. Business Overview & Revenue Model

Company DescriptionAmplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting of customized products. As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents. The company also sells its products through 1,350 franchisees. It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company was founded in 1950 and is headquartered in Milan, Italy.
How the Company Makes MoneyAmplifon generates revenue primarily through the sale of hearing aids and audiological services. The company operates a direct-to-consumer model through its extensive network of retail stores and online platforms, where customers can purchase hearing aids and receive professional fitting services. Key revenue streams include sales from hearing aids, ongoing maintenance and aftercare services, and audiological assessments. Additionally, Amplifon has established partnerships with various healthcare providers and insurance companies, which facilitate the distribution of its products and broaden its customer base. The company also benefits from strategic alliances with leading hearing aid manufacturers, allowing it to offer a diverse range of products and maintain competitive pricing.

Amplifon S.p.A. Financial Statement Overview

Summary
Amplifon S.p.A. demonstrates a stable financial position with strong cash flow generation. However, declining revenue and profitability margins highlight potential operational challenges. High leverage remains a risk factor.
Income Statement
65
Positive
Amplifon S.p.A. shows a mixed performance in its income statement. The gross profit margin is stable, indicating efficient cost management. However, the net profit margin has decreased over the TTM, reflecting reduced profitability. The revenue growth rate is negative in the TTM, suggesting a decline in sales. EBIT and EBITDA margins have also decreased slightly, indicating challenges in operational efficiency.
Balance Sheet
60
Neutral
The balance sheet reveals a high debt-to-equity ratio, indicating significant leverage, which could pose financial risks. Return on equity has decreased, reflecting lower profitability for shareholders. The equity ratio is moderate, suggesting a balanced asset structure but with room for improvement in reducing debt levels.
Cash Flow
70
Positive
Cash flow analysis shows strong free cash flow growth in the TTM, indicating improved cash generation capabilities. The operating cash flow to net income ratio is stable, suggesting consistent cash flow relative to earnings. However, the free cash flow to net income ratio has decreased, indicating potential challenges in converting profits into free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.41B2.41B2.26B2.12B1.95B1.56B
Gross Profit1.27B1.36B548.45M1.18B1.11B863.16M
EBITDA535.70M557.25M522.01M513.82M468.72M361.67M
Net Income115.62M145.37M155.14M178.53M157.78M101.00M
Balance Sheet
Total Assets3.84B3.99B3.69B3.58B3.52B3.23B
Cash, Cash Equivalents and Short-Term Investments237.31M288.85M194.00M229.54M318.44M554.02M
Total Debt1.89B1.72B1.52B1.50B1.61B1.56B
Total Liabilities2.87B2.84B2.59B2.54B2.59B2.43B
Stockholders Equity969.83M1.15B1.10B1.04B925.18M800.88M
Cash Flow
Free Cash Flow322.48M366.19M271.89M342.99M348.97M330.63M
Operating Cash Flow424.73M449.35M413.54M458.62M462.37M391.47M
Investing Cash Flow-210.42M-335.10M-261.48M-193.78M-533.61M-134.28M
Financing Cash Flow-139.26M-18.85M-135.06M-353.80M-208.64M151.52M

Amplifon S.p.A. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price13.59
Price Trends
50DMA
13.56
Positive
100DMA
14.16
Negative
200DMA
16.23
Negative
Market Momentum
MACD
-0.05
Positive
RSI
49.24
Neutral
STOCH
55.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AMP, the sentiment is Neutral. The current price of 13.59 is below the 20-day moving average (MA) of 13.63, above the 50-day MA of 13.56, and below the 200-day MA of 16.23, indicating a neutral trend. The MACD of -0.05 indicates Positive momentum. The RSI at 49.24 is Neutral, neither overbought nor oversold. The STOCH value of 55.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IT:AMP.

Amplifon S.p.A. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
€610.87M34.711.86%12.82%7.37%
63
Neutral
€518.47M23.795.24%11.25%-76.44%
57
Neutral
€3.05B26.4211.68%2.13%2.05%-25.46%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IT:AMP
Amplifon S.p.A.
13.59
-11.60
-46.06%
IT:PHN
PharmaNutra SpA
63.10
12.05
23.60%
IT:HI
Health Italia SpA
297.00
211.09
245.72%
IT:GHC
Garofalo Health Care S.P.A.
5.59
0.36
6.82%
IT:GPI
GPI SpA
18.00
8.68
93.13%
IT:SVS
Svas Biosana S.p.A.
8.80
0.99
12.68%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025